John Allen

Title: John Allen: Innovator in Imidazopyridine Derivatives

Introduction

John Allen is a notable inventor based in Voisins Le Bretonneux, France. He has made significant contributions to the field of chemistry, particularly in the development of imidazopyridine derivatives. With a total of 2 patents to his name, Allen's work has important therapeutic implications.

Latest Patents

Allen's latest patents include innovative compounds such as imidazopyridine derivatives and compositions containing them. These compounds are characterized by a general formula that allows for various substitutions, making them versatile in therapeutic applications. Another significant patent focuses on imidopyridines that are useful in therapy, showcasing the potential of these compounds in medical treatments.

Career Highlights

Throughout his career, John Allen has been associated with Synthelabo, a company known for its advancements in pharmaceutical research. His work has contributed to the development of new therapeutic agents, enhancing the company's portfolio in the field of medicinal chemistry.

Collaborations

Allen has collaborated with notable colleagues such as Pascal George and Guy Jaurand. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

John Allen's contributions to the field of chemistry, particularly through his patents on imidazopyridine derivatives, highlight his role as an influential inventor. His work continues to pave the way for advancements in therapeutic applications.